Risk of thromboembolic events in non-hospitalized COVID-19 patients: A systematic review-Reference-Cited by-同舟云学术

Risk of thromboembolic events in non-hospitalized COVID-19 patients: A systematic review

Published:2023-02 Issue: Volume:941 Page:175501
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Massoud Gaelle P.,Hazimeh Dana H.,Amin Ghadir,Mekary Wissam,Khabsa Joanne,Araji Tarek,Fares Souha,Mericskay Mathias,Booz George W.,Zouein Fouad A.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference34 articles.

1. The hypercoagulable state in COVID-19: incidence, pathophysiology, and management;Abou-Ismail;Thromb. Res.,2020

2. Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: multi-sourced population-based health records cohort study;Aktaa;Thromb. Res.,2021

3. Incidence, clinical characteristics, risk factors and outcomes of acute coronary syndrome in patients with Covid-19: results of the UMC-19-S10;al, A.A.-A.e;J. Emerg. Med.,2021

4. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia;Arachchillage;J. Thromb. Haemostasis,2020

5. Risk factors for death in 1859 subjects with COVID-19;Chen;Leukemia,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular disease risk after a SARS-CoV-2 infection: A systematic review and meta-analysis;Journal of Infection;2024-09

2. COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation;American Journal of Cardiovascular Drugs;2024-08-13

3. The thromboembolic effect of COVID-19;COVID-19’s Consequences on the Cardiovascular System;2024

4. COVID-19 in Patients with Drug-Resistant Tuberculosis in Lesotho;The American Journal of Tropical Medicine and Hygiene;2023-11-01

5. Long-Term Side Effects: A Mathematical Modeling of COVID-19 and Stroke with Real Data;Fractal and Fractional;2023-09-29